Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9239087Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2024
Linked Award Amount
$1.5M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#9,006
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Scot P Ouellette as a PI. Multi-PI records show the full award amount for context.
- 5R01AI170688-03R01Functional Analysis of the Clp Protease Systems in Chlamydial Growth and Differentiation$455.5Kaward amount
- 1R35GM151971-01R35Investigating the function of bacterial cytoskeletal elements in the division and growth of the FtsZ-less Chlamydia$394.5Kaward amount
- 1R21AI180574-01A1R21Characterizing the Function of Cyclic di-AMP on Chlamydial Growth and Differentiation$230.3Kaward amount
- 5R21AI178150-02R21Characterizing the Redoxome of Chlamydia and Its Host Cell$190.1Kaward amount
- 5R21AI171228-02R21Characterizing the Function of the Periplasmic Protease Tsp in Chlamydial Secondary Differentiation$188.9Kaward amount
Award organization
Organizations that administered FY2024 awards listing Scot P Ouellette as a PI.
FY2024 award administered by University of Nebraska Medical Center (NE).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Nebraska Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9006
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Scot P Ouellette.